Jia Pei Lim

Jia Pei Lim

South Australian Immunogenomics Cancer Institute

Faculty of Health and Medical Sciences

Dr. Jia Pei Lim is a postdoctoral researcher at the South Australian immunoGENomics Cancer Institute (SAiGENCI), University of Adelaide, with a strong background in cancer epigenetics and 3D chromatin biology. Her research focuses on histone methyltransferases and chromatin-modifying complexes in cancer, working under the supervision of Dr. Qi Zhang.

Dr. Lim has led high-impact research across institutions in Singapore, Sweden, and Australia. She completed her PhD in Cancer Biology at the National University of Singapore and previously held a postdoctoral position at Karolinska Institutet. Her work has resulted in nine peer-reviewed publications, including a co-first author paper in Nature Communications and a co-authored paper in Science Translational Medicine. Her research has been cited over 370 times (H-index: 9).

She is actively involved in the scientific community through conference presentations (e.g. CSHL, EMBL, AACR), professional memberships, and collaborative research with leading institutes such as RIKEN and A*STAR. Dr. Lim also serves on the SAiGENCI Early Career Researcher (ECR) Committee.

  • Appointments
    Date Position Institution name
    2025 - ongoing Post-doctoral researcher University of Adelaide
    2019 - 2023 Post-doctoral researcher Karolinska Institute

  • Awards and Achievements
    Date Type Title Institution Name Country Amount
    2014 Scholarship Ong Hin Tiang Scholarship in Cancer Research National University of Singapore Singapore -

  • Language Competencies
    Language Competency
    Chinese (Mandarin) Can read, write, speak and understand spoken
    English Can read, write, speak, understand spoken and peer review
    Malay Can read, write, speak and understand spoken

  • Education
    Date Institution name Country Title
    2014 - 2019 National University of Singapore Singapore PhD
    2008 - 2012 Universiti Putra Malaysia Malaysia Bachelor of Biomedical Sciences

  • Research Interests
    Epigenetics Cancer Cell Biology

  • Journals
    Year Citation
    2024 Neo, S. Y., Tong, L., Chong, J., Liu, Y., Jing, X., Oliveira, M. M. S., . . . Lundqvist, A. (2024). Tumor-associated NK cells drive MDSC-mediated tumor immune tolerance through the IL-6/ STAT3 axis. Science Translational Medicine, 16(747), 18 pages.
    DOI Scopus20 Europe PMC15
    2022 Chachoua, I., Tzelepis, I., Dai, H., Lim, J. P., Lewandowska-Ronnegren, A., Casagrande, F. B., . . . Göndör, A. (2022). Canonical WNT signaling-dependent gating of MYC requires a noncanonical CTCF function at a distal binding site. Nature Communications, 13(1), 13 pages.
    DOI Scopus16 Europe PMC16
    2019 Lim, J. P., Nair, S., Shyamasundar, S., Chua, P. J., Muniasamy, U., Matsumoto, K., . . . Bay, B. H. (2019). Silencing Y-box binding protein-1 inhibits triple-negative breast cancer cell invasiveness via regulation of MMP1 and beta-catenin expression. Cancer Letters, 452, 119-131.
    DOI Scopus46 Europe PMC36
    2018 Chua, P. J., Lim, J. P., Guo, T. T., Khanna, P., Hu, Q., Bay, B. H., & Baeg, G. H. (2018). Y-box binding protein-1 and STAT3 independently regulate ATP-binding cassette transporters in the chemoresistance of gastric cancer cells. International Journal of Oncology, 53(6), 2579-2589.
    DOI Scopus19 Europe PMC15
    2018 Soh, R. Y. Z., Lim, J. P., Samy, R. P., Chua, P. J., & Bay, B. H. (2018). A-kinase anchor protein 12 (AKAP12) inhibits cell migration in breast cancer. Experimental and Molecular Pathology, 105(3), 364-370.
    DOI Scopus19 Europe PMC15
    2018 Lim, J. P., Nair, S., Shyamasundar, S., Gunaratne, J., & Bay, B. H. (2018). Advanced quantitative mass-spectrometry-based SILAC proteome profiling of Y-box binding protein-1 (YB-1) overexpressing breast cancer cells unravels proteins involved in metastasis. CANCER RESEARCH, 78(13), 2 pages.
    DOI
    2017 Lim, J. P., Shyamasundar, S., Gunaratne, J., Scully, O. J., Matsumoto, K., & Bay, B. H. (2017). YBX1 gene silencing inhibits migratory and invasive potential via CORO1C in breast cancer in vitro. BMC Cancer, 17(1), 15 pages.
    DOI Scopus59 Europe PMC55
    2017 Lim, J. P., Baeg, G. H., Srinivasan, D. K., Dheen, S. T., & Bay, B. H. (2017). Potential adverse effects of engineered nanomaterials commonly used in food on the miRNome. Food and Chemical Toxicology, 109(Pt 1), 771-779.
    DOI Scopus24 Europe PMC7
    2016 Shyamasundar, S., Lim, J. P., & Bay, B. H. (2016). MiR-93 inhibits the invasive potential of triple-negative breast cancer cells in vitro via protein kinase WNK1. International Journal of Oncology, 49(6), 2629-2636.
    DOI Scopus57 Europe PMC44
    2014 Lim, J. P., Devaux, J., & Yuki, N. (2014). Peripheral nerve proteins as potential autoantigens in acute and chronic inflammatory demyelinating polyneuropathies. Autoimmunity Reviews, 13(10), 1070-1078.
    DOI Scopus34 Europe PMC23

  • Committee Memberships
    Date Role Committee Institution Country
    2025 - ongoing Member SAiGENCI ECR Committee SAiGENCI Australia
    2015 - 2017 Board Member Safety Committee National University of Singapore Singapore

  • Memberships
    Date Role Membership Country
    2018 - 2019 Member Microscopy Society (Singapore) Singapore
    2017 - ongoing Member American Association for Cancer Research (AACR) United States
    2017 - 2023 Member European Association for Cancer Research (EACR) United Kingdom
    2017 - 2022 Member Singapore Society for Mass Spectrometry (SSMS) Singapore
Connect With Me
External Profiles